Wolverine Asset Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-3,125
Closed -$300K – 1906
2023
Q2
$300K Hold
3,125
– – ﹤0.01% 939
2023
Q1
$315K Buy
+3,125
New +$479K ﹤0.01% 947
2022
Q2
– Sell
-5,000
Closed -$3.47M – 2373
2022
Q1
$3.47M Hold
5,000
– – 0.03% 379
2021
Q4
$4.52M Hold
5,000
– – 0.04% 331
2021
Q3
$5.03M Buy
+5,000
New +$3.68M 0.04% 280

Other funds holding GOSS

Wolverine Asset Management's GOSS Position: Q3 2026 in Review

Wolverine Asset Management sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 161,184 shares — an estimated $2.12M sold.

Wolverine Asset Management first reported a position in GOSS in Q2 2026 and held it in 1 quarter. The position peaked at $2.12M in Q2 2026. 24 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Wolverine Asset Management reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 161,184 Gossamer Bio shares in Q3 2026, an estimated $2.12M.
  • Wolverine Asset Management first reported a position in Gossamer Bio in Q2 2026 and held it in 1 quarter.
  • Wolverine Asset Management's Gossamer Bio position peaked at $2.12M in Q2 2026.
  • 24 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.